药明康德：利息费用不仅来自长短期借款

证券之星05-29 17:11

证券之星消息，XD药明康(603259)05月29日在投资者关系平台上答复投资者关心的问题。

投资者提问：药明康德2026年1季度报表的资产负债表中短期借款与长期借款合计77.9亿元，2025年1季度报表的资产负债表中短期借款与长期借款合计55.57亿元。但26年1季度的报表中确认的利息费用是3095.29万元，25年1季度报表确认的利息费用是6576.11万元。借款金额上涨，但利息费用却大幅下降，请问原因是什么？

XD药明康回复：您好，感谢您对公司的关注。财务报表中的‘利息费用’不仅来自于银行的长短期借款，也包含了可转债以及租赁负债等其他带息债务项目所计提的利息费用。因此，借款合计金额与利息费用呈现不完全同步变动。

本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。

相关 ETF

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2639230526?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-05-29 17:11","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2639230526","market":"sh","top_or_hot":-1,"title":"药明康德：利息费用不仅来自长短期借款","media":"证券之星","content":"<html><body><p>证券之星消息，XD药明康(603259)05月29日在投资者关系平台上答复投资者关心的问题。</p><p>投资者提问：<a href=\"https://laohu8.com/S/603259\">药明康德</a>2026年1季度报表的资产负债表中短期借款与长期借款合计77.9亿元，2025年1季度报表的资产负债表中短期借款与长期借款合计55.57亿元。但26年1季度的报表中确认的利息费用是3095.29万元，25年1季度报表确认的利息费用是6576.11万元。借款金额上涨，但利息费用却大幅下降，请问原因是什么？</p><p>XD药明康回复：您好，感谢您对公司的关注。财务报表中的‘利息费用’不仅来自于银行的长短期借款，也包含了可转债以及租赁负债等其他带息债务项目所计提的利息费用。因此，借款合计金额与利息费用呈现不完全同步变动。</p><p>本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。</p><h2>相关 ETF</h2><p><img src=\"https://static.stockstar.com/etf/15991520260529.png\"/><img src=\"https://static.stockstar.com/etf/58827020260529.png\"/><img src=\"https://static.stockstar.com/etf/51201020260529.png\"/><img src=\"https://static.stockstar.com/etf/51608020260529.png\"/></p></body></html>","source":"stockstar","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>药明康德：利息费用不仅来自长短期借款</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n药明康德：利息费用不仅来自长短期借款\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-05-29 17:11 北京时间&nbsp;&nbsp;&nbsp;<a href=https://stock.stockstar.com/RB2026052900031621.shtml><strong>证券之星</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>证券之星消息，XD药明康(603259)05月29日在投资者关系平台上答复投资者关心的问题。投资者提问：药明康德2026年1季度报表的资产负债表中短期借款与长期借款合计77.9亿元，2025年1季度报表的资产负债表中短期借款与长期借款合计55.57亿元。但26年1季度的报表中确认的利息费用是3095.29万元，25年1季度报表确认的利息费用是6576.11万元。借款金额上涨，但利息费用却大幅下降，...</p>\n\n<a href=\"https://stock.stockstar.com/RB2026052900031621.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1808992512.USD","symbol_name":"AB ALL CHINA EQUITY PORTFOLIO \"A\" (USD) ACC","start_time":0,"source_url":"https://stock.stockstar.com/RB2026052900031621.shtml","article_id":"2639230526","we_media_id":"1082532455","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2639230526","pubTimestamp":1780045869,"columns":[],"sourceInfo":{"source_id":"stockstar","name":"证券之星"},"weMediaInfo":{"media_name":"证券之星","introduction":"证券之星始创于1996年，是国内领先的金融信息及综合服务平台。关注证券之星，即时获取有价值的财经资讯。","home_visible":1,"id":"1082532455","head_image":"https://community-static.tradeup.com/news/2e305640fc27210243042d09d3a7fa3f"},"summary":"证券之星消息，XD药明康05月29日在投资者关系平台上答复投资者关心的问题。投资者提问：药明康德2026年1季度报表的资产负债表中短期借款与长期借款合计77.9亿元，2025年1季度报表的资产负债表中短期借款与长期借款合计55.57亿元。XD药明康回复：您好，感谢您对公司的关注。因此，借款合计金额与利息费用呈现不完全同步变动。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"603259":"药明康德","LU1808992512.USD":"AB ALL CHINA EQUITY PORTFOLIO \"A\" (USD) ACC","IE00B543WZ88.USD":"NEUBERGER BERMAN CHINA EQUITY \"A\" (USD) ACC","LU1303224171.USD":"NINETY ONE GSF ALL CHINA EQUITY \"A\" (USD) INC","02359":"药明康德","LU0456842615.SGD":"JPMorgan Funds - Emerging Markets Equity A (acc) SGD","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","LU1997245177.USD":"安联神洲A股基金","LU1719994722.HKD":"NINETY ONE GSF ALL CHINA EQUITY \"A\" (HKD) ACC","BK1583":"高瓴概念","LU2045819591.USD":"Natixis WCM Global Emerging Markets Equity R/A USD","LU0052750758.USD":"富兰克林中国基金A Acc","LU0320764599.SGD":"FTIF - Templeton China A Acc SGD","BK0216":"研究试验","LU1770034418.SGD":"ALL CHINA EQUITY \"A\" (SGDHDG) ACC","LU1997245094.SGD":"安联神州A股基金AT Acc SGD","LU0708995583.HKD":"TEMPLETON CHINA \"A\" (HKD) ACC","LU2125910500.SGD":"Natixis WCM Global Emerging Markets Equity H-R/A SGD","IE00B5MMRT66.SGD":"NEUBERGER BERMAN CHINA EQUITY \"A\" (SGDHDG) ACC","LU1934453819.USD":"AB CHINA A SHARES EQUITY PORTFOLIO \"A\" (USD) ACC","LU2495084118.USD":"ALLIANZ CHINA A-SHARES \"ATH\" (USDHDG) ACC","LU1979443071.USD":"AB CHINA A SHARES EQUITY PORTFOLIO \"AD\" (USDHDG) INC","LU1969619763.USD":"EASTSPRING INV CHINA A SHARES GROWTH \"A\" (USD) ACC","LU1046422090.SGD":"Fidelity Pacific A-SGD","LU0348766576.USD":"ALLIANZ LITTLE DRAGONS \"A\" (USD) INC","LU1997244956.HKD":"ALLIANZ CHINA A-SHARES \"AT\" (HKD) ACC A","LU0348767384.USD":"ALLIANZLITTLE DRAGONS \"A\" (USD) ACC","BK1141":"生命科学工具和服务","BK1576":"医药外包概念","LU2242644610.SGD":"Fidelity China Innovation A-ACC-SGD","IE00BPRC5H50.USD":"NEUBERGER BERMAN CHINA EQUITY \"A\" (USD) INC","LU1251922891.USD":"NINETY ONE GSF ALL CHINA EQUITY \"A\" (USD) ACC","LU2328871848.SGD":"Eastspring Investments - China A Shares Growth AS SGD"},"translate_title":"WuXi AppTec: Interest expenses not only come from long-term and short-term borrowings","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"603259":1.5,"02359":1.5},"content_text":"证券之星消息，XD药明康(603259)05月29日在投资者关系平台上答复投资者关心的问题。投资者提问：药明康德2026年1季度报表的资产负债表中短期借款与长期借款合计77.9亿元，2025年1季度报表的资产负债表中短期借款与长期借款合计55.57亿元。但26年1季度的报表中确认的利息费用是3095.29万元，25年1季度报表确认的利息费用是6576.11万元。借款金额上涨，但利息费用却大幅下降，请问原因是什么？XD药明康回复：您好，感谢您对公司的关注。财务报表中的‘利息费用’不仅来自于银行的长短期借款，也包含了可转债以及租赁负债等其他带息债务项目所计提的利息费用。因此，借款合计金额与利息费用呈现不完全同步变动。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。相关 ETF","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2639230526","isCrawlerRequest":true}